Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects [PDF]
Frontiers in Microbiology, 2018 Carbapenem-resistant Enterobacteriaceae (CRE), a major resistance concern emerging during the last decade because of significantly compromising the efficacy of carbapenem agents, has currently become an important focus of infection control.
Shio-Shin Jean +8 more
doaj +6 more sources
Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections [PDF]
Emerging Infectious Diseases, 2014 We evaluated the number of deaths attributable to carbapenem-resistant Enterobacteriaceae by using studies from around the world published before April 9, 2012.
Matthew E. Falagas +3 more
doaj +4 more sources
Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children. [PDF]
J Pediatric Infect Dis Soc, 2020 AbstractInfections due to carbapenem-resistant Enterobacteriaceae (CRE) are increasingly prevalent in children and are associated with poor clinical outcomes. Optimal treatment strategies for CRE infections continue to evolve. A lack of pediatric-specific comparative effectiveness data, uncertain pediatric dosing regimens for several agents, and a ...
Chiotos K, Hayes M, Gerber JS, Tamma PD.
europepmc +5 more sources
Paediatric Enterobacteriaceae infections in hospitalised children in Durban, KwaZulu-Natal
Southern African Journal of Infectious Diseases, 2021 Background: Community-acquired Gram-negative Enterobacteriaceae infections in malnourished and HIV-infected hospitalised children are not well documented and are of concern because of increasing antibiotic resistance and limited available treatment ...
Harshna Krishinchand +3 more
doaj +2 more sources
Carbapenem and colistin resistance in children with Enterobacteriaceae infections [PDF]
The Turkish Journal of Pediatrics, 2020 Background. Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. As a reserve agent, colistin has been the drug of choice for the treatment of infections caused by CRE.
Zeliha Haytoğlu +5 more
doaj +3 more sources
The Clinical and Molecular Epidemiology of CTX-M-9 Group Producing Enterobacteriaceae Infections in Children. [PDF]
Infect Dis Ther, 2019 Logan LK +12 more
europepmc +3 more sources
A matched case-control study to assess the carbapenem-resistant Enterobacteriaceae infections among hospitalized children at King Fahad Medical City, Riyadh, Saudi Arabia. [PDF]
Saudi Med J, 2019 Alzomor OA +4 more
europepmc +3 more sources
Antibiotic resistance pattern of clinical isolates of ESBL strains and determination of enzymatic relationship with clinical specimen type [PDF]
مجله پزشکی دانشگاه علوم پزشکی تبریز, 2020 Background: Differences in clinical isolates may affect the frequency of Extended Spectrum Beta-Lactamase enzymes (ESBLs) in some gram-negative bacteria.
Mahyar Porbaran +2 more
doaj +1 more source
Extended-Spectrum beta (β)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia. [PDF]
PLoS ONE, 2016 The spread of Extended-Spectrum beta (β)-Lactamases (ESBL)-producing Enterobacteriaceae has become a serious global problem. ESBL-producing Enterobacteriaceae vary based on differences in antibiotic use, nature of patients and hospital settings.
Bayeh Abera +2 more
doaj +1 more source
Differential DNA accessibility to polymerase enables 30-minute phenotypic β-lactam antibiotic susceptibility testing of carbapenem-resistant Enterobacteriaceae [PDF]
, 2020 The rise in carbapenem-resistant Enterobacteriaceae (CRE) infections has created a global health emergency, underlining the critical need to develop faster diagnostics to treat swiftly and correctly.
Garner, Omai B. +5 more
core +1 more source